Lakewood-Amedex Biotherapeutics Statistics
NASDAQ: LABTHealthcareBiotechnologyUSD
0.792-0.0578 (-6.80%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 0.8064 +1.82%
Lakewood-Amedex Biotherapeutics by the numbers
Lakewood-Amedex Biotherapeutics has a market capitalization of $1.9 million based on 2.37M shares outstanding. With trailing EPS of $-8.83, Lakewood-Amedex Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 59.3% below its 50-day average and 90.3% below its 200-day average.
Average daily trading volume is 2.50M shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LABT valuation vs. peer median
| Metric | LABT | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.88M | $1.90M | -1% |
| Avg. volume | 2.50M | 638.96K | +291% |
Peer median across 8 companies: ARTL, VBIO, EDVA, CRIS, OGEN, SCNI, GNPX, TCRT.
Valuation
- Market cap
- $1.88M
- EPS (TTM)
- $-8.83
- Shares outstanding
- 2.37M
Price and trading
- Previous close
- 0.8498
- Open
- 0.815
- Day range
- 0.78 – 0.8254
- 52-week range
- 0.76 – 98.20
- Beta
- —
- Volume
- 214.58K
- Average volume
- 2.50M
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 1.88M
- Eps
- -8.83
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 98.20
- Week52 Low
- 0.76
- Avg Volume
- 2.50M
- Shares Outstanding
- 2.37M
- Ma50
- 1.95
- Ma200
- 8.15
- Pct From52w High
- -99.19%
- Pct From52w Low
- 4.21%